Reuters logo
BRIEF-Oncobiologics ‍enters into purchase agreement with GMS Tenshi
September 8, 2017 / 1:01 PM / 16 days ago

BRIEF-Oncobiologics ‍enters into purchase agreement with GMS Tenshi

Sept 8 (Reuters) - Oncobiologics Inc

* Oncobiologics Inc - ‍entered into a purchase agreement on September 7, 2017 with GMS Tenshi Holdings PTE. Limited​

* Oncobiologics Inc - ‍ purchase agreement provides for private placement of up to $25.0 million of Oncobiologics’ series A convertible preferred stock​

* Oncobiologics- Purchase deal also provides for warrants to acquire up to additional 16.8 million shares of common stock having exercise price of about $15 million​

* Oncobiologics Inc - License supersedes and replaces a previous strategic license agreement entered into on July 25, 2017 with GMS Tenshi

* Oncobiologics - To use proceeds from private placement primarily for initiation of phase 3 clinical trials for lead biosimilar candidate, ONS-3010 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below